000			01399 a2200433 4500
005			20250511164913.0
264		0	_c19750505
008			197505s 0 0 eng d
022			_a0098-7484
040			_aNLM _beng _cNLM
245	0	0	_aReport of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents. _h[electronic resource]
260			_bJAMA _cFeb 1975
300			_a583-608 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aBiometry
650	0	4	_aCardiovascular Diseases _xmortality
650	0	4	_aClinical Trials as Topic
650	0	4	_aDiabetes Mellitus _xdiet therapy
650	0	4	_aDiet, Diabetic
650	0	4	_aEvaluation Studies as Topic
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHeart _xdrug effects
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aModels, Theoretical
650	0	4	_aOperations Research
650	0	4	_aPhenformin _xtherapeutic use
650	0	4	_aPlacebos
650	0	4	_aSex Factors
650	0	4	_aTime Factors
650	0	4	_aTolbutamide _xadverse effects
773	0		_tJAMA _gvol. 231 _gno. 6 _gp. 583-608
999			_c1097045 _d1097045